At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
LNSR LENSAR Inc
Trading 11-15 11:57:02 EST
7.45
+0.25
+3.40%
High7.65
Low7.01
Vol29.86K
Open7.01
D1 Closing7.20
Amplitude8.89%
Mkt Cap86.42M
Tradable Cap63.25M
Total Shares11.61M
T/O223.37K
T/O Rate0.35%
Tradable Shares8.50M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
LENSAR Third Quarter 2024 Earnings: Beats Expectations
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its LENSAR Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision. The company also offers Adaptive Cataract Treatment System, a platform design to femtosecond laser technology features that enhanced laser capabilities into a single small unit that allows surgeons to perform a femtosecond laser assisted cataract procedure in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida.